Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.

Human plasma kallikrein participates in the contact activation system of plasma. The light chain of kallikrein contains the enzymatic active site; the heavy chain is required for binding to high molecular weight kininogen and for surface-dependent activation of coagulation. This study has examined the functional contributions of the heavy chain of kallikrein and of high molecular weight kininogen in the inactivation of kallikrein and of its isolated light chain by alpha 2-macroglobulin (alpha 2M). Irreversible inhibition was observed for both kallikrein and its light chain, with the initial formation of a reversible enzyme-inhibitor complex. The second-order rate constants for these reactions were 3.5 X 10(5) and 4.8 X 10(5) M-1 min-1 for kallikrein and its light chain, respectively. When present in excess, high molecular weight kininogen decreased the rate of kallikrein inactivation by alpha 2M, whereas the rate of inactivation of the light chain was unaffected by high molecular weight kininogen. Although at a drastically reduced rate, high molecular weight kininogen was cleaved by alpha 2M-bound kallikrein. Sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis was used to study complex formation between alpha 2M and kallikrein or its light chain. Under reducing conditions, four kallikrein-alpha 2M complexes were observed. Three of these complexes consisted of alpha 2M and the light chain of kallikrein (Mr 123 000, 235 000, and 330 000). Two alpha 2M-kallikrein light chain complexes incorporated [3H]diisopropyl fluorophosphate ( [3H]DFP) whereas the Mr 330 000 complex did not react with [3H]DFP.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Griffin,et al.  Interaction of human plasma kallikrein and its light chain with C1 inhibitor. , 1983, Biochemistry.

[2]  F van der Graaf,et al.  Inactivation of kallikrein in human plasma. , 1983, Journal of Clinical Investigation.

[3]  J. Griffin,et al.  Isolation and functional properties of the heavy and light chains of human plasma kallikrein. , 1982, The Journal of biological chemistry.

[4]  R. Colman,et al.  High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. , 1982, Biochemistry.

[5]  R. Colman,et al.  Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. , 1982, The Journal of clinical investigation.

[6]  R. Feinman,et al.  The reaction of alpha 2-macroglobulin-bound trypsin with soybean trypsin inhibitor. , 1981, The Journal of biological chemistry.

[7]  R. Feinman,et al.  Inhibition of proteases by alpha 2-macroglobulin. The role of lysyl amino groups of trypsin in covalent complex formation. , 1981, The Journal of biological chemistry.

[8]  F. van Leuven,et al.  Functional modifications of alpha 2-macroglobulin by primary amines. II. Inhibition of covalent binding of trypsin to alpha 2 M by methylamine and other primary amines. , 1981, The Journal of biological chemistry.

[9]  J. Bieth,et al.  Inhibition of alpha 2-macroglobulin-bound trypsin by soybean trypsin inhibitor. , 1981, The Journal of biological chemistry.

[10]  A. Barrett,et al.  Further characterization of the covalent linking reaction of alpha 2-macroglobulin. , 1981, The Biochemical journal.

[11]  J. Howard.  Reactive site in human alpha 2-macroglobulin: circumstantial evidence for a thiolester. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Magnusson,et al.  A thiol‐ester in α2‐macroglobulin cleaved during proteinase complex formation , 1980 .

[13]  A. Barrett,et al.  Covalent binding of proteinases in their reaction with alpha 2-macroglobulin. , 1980, The Biochemical journal.

[14]  J. Griffin,et al.  Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. , 1980, The Journal of biological chemistry.

[15]  J. Griffin,et al.  Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate. , 1980, Biochemistry.

[16]  R. Colman,et al.  Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. , 1980, The Journal of clinical investigation.

[17]  J. Griffin,et al.  Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. , 1979, The Journal of biological chemistry.

[18]  M. Laskowski,et al.  Purification of human plasma alpha 2 macroglobulin and alpha 1 proteinase inhibitor using zinc chelate chromatography. , 1979, Analytical biochemistry.

[19]  J. Howard,et al.  Characterization of alkylamine-sensitive site in alpha 2-macroglobulin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Kaplan,et al.  Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. , 1977, The Journal of biological chemistry.

[21]  R. Colman,et al.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. , 1977, The Journal of clinical investigation.

[22]  J. Griffin,et al.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. , 1977, The Journal of clinical investigation.

[23]  R. Colman,et al.  Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Griffin,et al.  Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. M. Fleming,et al.  Effect of α2 macroglobulin on some kinetic parameters of trypsin , 1975 .

[26]  R. Reisfeld,et al.  Protein iodination with solid state lactoperoxidase. , 1974, Biochemistry.

[27]  K. Wuepper,et al.  ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES , 1973, The Journal of experimental medicine.

[28]  M. Mosesson,et al.  Degradation of Human Fibrinogen by Plasma α2-Macroglobulin-Enzyme Complexes , 1973 .

[29]  P. Harpel.  STUDIES ON HUMAN PLASMA α2-MACROGLOBULIN-ENZYME INTERACTIONS , 1973, The Journal of experimental medicine.

[30]  A. Barrett,et al.  The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism , 1973 .

[31]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[32]  D. McConnell.  Inhibitors of kallikrein in human plasma. , 1972, The Journal of clinical investigation.

[33]  Kaplan Ap,et al.  A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  P. Harpel.  HUMAN PLASMA ALPHA 2-MACROGLOBULIN , 1970, The Journal of experimental medicine.

[36]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[37]  R. Kitz,et al.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. , 1962, The Journal of biological chemistry.

[38]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.